These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7607335)

  • 21. [Glucose toxicity--pros and cons. Useful adaptation and common cause of insulin resistance in diabetic patients].
    Yki-Järvinen H
    Nord Med; 1996 Mar; 111(3):80-3. PubMed ID: 8628644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Physiopathological mechanisms in type 1 and type 2 diabetes].
    Boitard Ch
    Arch Mal Coeur Vaiss; 2004 Dec; 97 Spec No 3():7-12. PubMed ID: 15666475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro reversal of hyperglycemia normalizes insulin action in fat cells from type 2 diabetes patients: is cellular insulin resistance caused by glucotoxicity in vivo?
    Burén J; Lindmark S; Renström F; Eriksson JW
    Metabolism; 2003 Feb; 52(2):239-45. PubMed ID: 12601640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection of pancreatic beta-cells: is it feasible?
    Bonora E
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dietary effects on insulin and nutrient metabolism in mesenteric lymph node cells, splenocytes, and pancreatic islets of BB rats.
    Scott FW; Olivares E; Sener A; Malaisse WJ
    Metabolism; 2000 Sep; 49(9):1111-7. PubMed ID: 11016889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: the role of skeletal muscle glucose uptake and hepatic glucose production in the development of hyperglycaemia. A critical comment.
    Beck-Nielsen H; Hother-Nielsen O; Vaag A; Alford F
    Diabetologia; 1994 Feb; 37(2):217-21. PubMed ID: 8163059
    [No Abstract]   [Full Text] [Related]  

  • 27. Acute and chronic effects of hyperglycaemia on glucose metabolism.
    Yki-Järvinen H
    Diabetologia; 1990 Oct; 33(10):579-85. PubMed ID: 2257995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging concepts in the pathophysiology of type 2 diabetes mellitus.
    Surampudi PN; John-Kalarickal J; Fonseca VA
    Mt Sinai J Med; 2009 Jun; 76(3):216-26. PubMed ID: 19421965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The key to glucose: a guide to the hormone (and protein) insulin.
    Gebel E
    Diabetes Forecast; 2011 Oct; 64(10):32, 35. PubMed ID: 22010364
    [No Abstract]   [Full Text] [Related]  

  • 30. Banting memorial lecture 2013. A life in balance: wandering the pathways of control.
    Amiel SA
    Diabet Med; 2014 Apr; 31(4):382-92. PubMed ID: 24765675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular dysfunction in diabetes mellitus.
    Feener EP; King GL
    Lancet; 1997 Jul; 350 Suppl 1():SI9-13. PubMed ID: 9250277
    [No Abstract]   [Full Text] [Related]  

  • 32. Management of endocrine disease: Diabetes and osteoporosis: cause for concern?
    Starup-Linde J; Vestergaard P
    Eur J Endocrinol; 2015 Sep; 173(3):R93-9. PubMed ID: 26243638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Physiopathology of non-insulin-dependent diabetes: current data and therapeutic consequences].
    Broussolle C; Orgiazzi J; Noël G
    Rev Med Interne; 1990; 11(2):142-8. PubMed ID: 2204978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A rise at dawn. Why does blood glucose spike in the a.m.?
    Gebel E
    Diabetes Forecast; 2012 Mar; 65(3):28, 30. PubMed ID: 22439376
    [No Abstract]   [Full Text] [Related]  

  • 35. Mitochondrial dysfunction and complications associated with diabetes.
    Blake R; Trounce IA
    Biochim Biophys Acta; 2014 Apr; 1840(4):1404-12. PubMed ID: 24246956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Blood glucose fluctuation and activation of oxidative stress in diabetes].
    Yang QL; Gong CX
    Zhonghua Er Ke Za Zhi; 2012 Jul; 50(7):554-6. PubMed ID: 22932020
    [No Abstract]   [Full Text] [Related]  

  • 37. Stress and autonomic nervous system in type II diabetes. A hypothesis.
    Surwit RS; Feinglos MN
    Diabetes Care; 1988 Jan; 11(1):83-5. PubMed ID: 3276481
    [No Abstract]   [Full Text] [Related]  

  • 38. Insulin resistance due to hyperglycaemia: an adaptation protecting insulin-sensitive tissues.
    Yki-Järvinen H; Mäkimattila S
    Diabetologia; 1997 Jul; 40 Suppl 2():S141-4. PubMed ID: 9248723
    [No Abstract]   [Full Text] [Related]  

  • 39. Insulin-mediated and non-insulin-mediated metabolic effects of gastroenteropancreatic peptides in type I and type II diabetes.
    Dupre J; Baer A; Lee M; McDonald TJ; Radziuk J; Rodger NW; Sullivan S
    Adv Exp Med Biol; 1985; 189():207-25. PubMed ID: 4036714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucose toxicity.
    Yki-Järvinen H
    Endocr Rev; 1992 Aug; 13(3):415-31. PubMed ID: 1425483
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.